VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,016 | -26.0% | 1,785 | -17.2% | 0.00% | 0.0% |
| Q2 2023 | $64,884 | -6.9% | 2,155 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $69,691 | +4.1% | 2,155 | -7.8% | 0.00% | 0.0% |
| Q4 2022 | $66,954 | -15.2% | 2,337 | -28.5% | 0.00% | -50.0% |
| Q3 2022 | $79,000 | -11.2% | 3,267 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $89,000 | -85.7% | 3,267 | -79.9% | 0.00% | -81.8% |
| Q1 2022 | $624,000 | +743.2% | 16,267 | +605.1% | 0.01% | +1000.0% |
| Q4 2021 | $74,000 | +8.8% | 2,307 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $68,000 | -9.3% | 2,307 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $75,000 | -13.8% | 2,207 | -17.5% | 0.00% | -50.0% |
| Q1 2021 | $87,000 | -10.3% | 2,675 | -1.1% | 0.00% | 0.0% |
| Q4 2020 | $97,000 | +438.9% | 2,705 | +478.0% | 0.00% | – |
| Q3 2020 | $18,000 | -75.3% | 468 | -83.0% | 0.00% | -100.0% |
| Q3 2016 | $73,000 | -3.9% | 2,745 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $76,000 | – | 2,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |